Antares Pharma Inc. (ATRS: Quote) has jumped in early trading on Tuesday, boosted by positive results for a clinical trial.
Shares of Antares are up $0.28, or 7.8 percent, to $3.88.
The company announced positive results from a human factors usability study for VIBEX Methotrexate, a proprietary auto injector product designed to self-administer a rapid subcutaneous weekly injection of methotrexate for the treatment of rheumatoid arthritis.
Click here to receive FREE breaking news email alerts for Antares Pharma Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com